ConductScience.org, home

Genes

Open

193,990 genes from NCBI Gene. Counted 2026-11-11.

193,990 genes

Most papers first161 to 180 of 193,990

Show the results as
GeneNCBI GeneProteinsPatentsDrugsTrialsNIH grantsPapers
IFNB1

interferon beta 1

3456

HGNC:5434

14711514,02136,982
CDKN1A

cyclin dependent kinase inhibitor 1A

1026

HGNC:1784

12280013,29536,907
CD68

CD68 molecule

968

HGNC:1693

1920012,75236,601
MUC1

mucin 1, cell surface associated

4582

HGNC:7508

119416206,66736,545
LYZ

lysozyme

4069

HGNC:6740

11300010,88136,383
SOX2

SRY-box transcription factor 2

6657

HGNC:11195

13590014,10636,341
CASP8

caspase 8

841

HGNC:1509

112421411,07836,248
CCL5

C-C motif chemokine ligand 5

6352

HGNC:10632

12160015,60235,734
TLR2

toll like receptor 2

7097

HGNC:11848

11232713,71035,324
HMOX1

heme oxygenase 1

3162

HGNC:5013

1101008,66835,166
STAT1

signal transducer and activator of transcription 1

6772

HGNC:11362

11270015,71535,016
SIRT1

sirtuin 1

23411

HGNC:14929

11402410,02534,814
HGF

hepatocyte growth factor

3082

HGNC:4893

139522711,52534,808
ABL1

ABL proto-oncogene 1, non-receptor tyrosine kinase

25

HGNC:76

187361,46710,67534,797
RHO

rhodopsin

6010

HGNC:10012

11130016,87234,780
GLP1R

glucagon like peptide 1 receptor

2740

HGNC:4324

165171,3836,42234,487
ALK

ALK receptor tyrosine kinase

238

HGNC:427

1115203396,15734,371
FOS

Fos proto-oncogene, AP-1 transcription factor subunit

2353

HGNC:3796

11180017,31434,352
HLA-G

major histocompatibility complex, class I, G

3135

HGNC:4964

12750010,21534,063
PPARA

peroxisome proliferator activated receptor alpha

5465

HGNC:9232

1892726211,31034,033

Request

GET /api/genes/v1

A gene symbol, alias or name, an NCBI Gene, HGNC, Ensembl or UniProt ID, or a drug's name or ChEMBL ID.

No key needed

Response

The first 2 of this page's 20 results. GET /api/genes/v1?page=9

{
  "data": {
    "total": 193990,
    "results": [
      {
        "id": "3456",
        "title": "IFNB1: interferon beta 1",
        "summary": "NCBI Gene 3456. 1 protein, 471 patents, 1 drug, 5 trials, 14,021 NIH grants and 36,982 papers.",
        "record": "/library/genes/3456",
        "gene_id": 3456,
        "symbol": "IFNB1",
        "name": "interferon beta 1",
        "hgnc_id": "HGNC:5434",
        "counts": {
          "proteins": 1,
          "patents": 471,
          "drugs": 1,
          "trials": 5,
          "grants": 14021,
          "papers": 36982
        }
      },
      {
        "id": "1026",
        "title": "CDKN1A: cyclin dependent kinase inhibitor 1A",
        "summary": "NCBI Gene 1026. 1 protein, 228 patents, 0 drugs, 0 trials, 13,295 NIH grants and 36,907 papers.",
        "record": "/library/genes/1026",
        "gene_id": 1026,
        "symbol": "CDKN1A",
        "name": "cyclin dependent kinase inhibitor 1A",
        "hgnc_id": "HGNC:1784",
        "counts": {
          "proteins": 1,
          "patents": 228,
          "drugs": 0,
          "trials": 0,
          "grants": 13295,
          "papers": 36907
        }
      }
    ],
    "columns": [
      {
        "key": "symbol",
        "label": "Gene",
        "under": "name"
      },
      {
        "key": "id",
        "label": "NCBI Gene",
        "under": "hgnc_id"
      },
      {
        "key": "counts.proteins",
        "label": "Proteins"
      },
      {
        "key": "counts.patents",
        "label": "Patents"
      },
      {
        "key": "counts.drugs",
        "label": "Drugs"
      },
      {
        "key": "counts.trials",
        "label": "Trials"
      },
      {
        "key": "counts.grants",
        "label": "NIH grants"
      },
      {
        "key": "counts.papers",
        "label": "Papers"
      }
    ],
    "order": "Most papers first"
  },
  "release": "gene-search-2026-11-11-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ChEMBL, through Open Targets",
      "license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": "CC BY-SA 3.0"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "None stated"
    },
    {
      "source": "EMBL-EBI's patent proteins",
      "license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
      "notice": null,
      "short": "No added restrictions. Attribution expected"
    },
    {
      "source": "GenBank's patent files",
      "license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
      "notice": null,
      "short": "No restrictions from NCBI. Submitters may hold rights"
    },
    {
      "source": "HGNC",
      "license": "CC0: https://www.genenames.org/about/license/",
      "notice": null,
      "short": "CC0"
    },
    {
      "source": "NCBI Gene",
      "license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
      "notice": null,
      "short": "None named. Public domain as US government information"
    },
    {
      "source": "NIH's project files and grant-paper links",
      "license": "Public domain (NIH RePORTER)",
      "notice": null,
      "short": "Public domain"
    },
    {
      "source": "Open Targets",
      "license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": "CC0 1.0"
    },
    {
      "source": "PubTator 3",
      "license": "Public domain",
      "notice": null,
      "short": "Public domain"
    },
    {
      "source": "UniProt",
      "license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
      "notice": null,
      "short": "CC BY 4.0"
    }
  ],
  "next": "/api/genes/v1?page=10",
  "request_id": "CrFrHdlr_6w2rKk5"
}
gene-search-2026-11-11-0.1.0Next page

Sources 11

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNone stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GeneNone named. Public domain as US government information
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Open611,552 trials2026-11-12

Trial comparisons

ClinicalTrials.gov

Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.

Open85,013 comparisons2026-11-10

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

For invited accounts.

Opens sequences.conductscience.org

By invitation39,249,078 sequences2026-11-05

For software

Read Genes from software.

Every answer on this page is also JSON, under /api/genes/v1. No key.

GET https://conductscience.org/api/genes/v1?q=p53

Ask an assistant

  • Which drugs act on PCSK9, and which of their trials posted results?
  • How many patents list the exact protein sequence of TP53?
  • Which genes does evolocumab act on?
  • Which NIH grants have the most papers about APOE?